Novacyt has launched a diagnostic test for the new strain of coronavirus, which originated in Wuhan and has spread worldwide, leading the World Health Organization (WHO) to declare a global health emergency.
Novacyt stock soared 32% on Friday morning after the French cellular diagnostics company announced the launch of a new test for the coronavirus.
The test has been developed as a direct response to the recent outbreak of the new strain of coronavirus, which originated in the Chinese city of Wuhan and has now spread worldwide, leading the World Health Organization (WHO) to declare a global health emergency.
The death toll has now hit 213 with confirmed cases rising to 9,692, according to Chinese health officials. Coronaviruses are a large family of viruses that usually infect animals but can sometimes evolve and spread to humans. The new test is able to detect only the 2019 strain of the virus, reducing the risk of a false diagnosis, the company said in a statement.
The test, generated by the company’s Primerdesign molecular diagnostics team, can also generate a result in less than two hours, enabling samples to be screened quickly, which the company says could help prevent the “unnecessary” spread of the virus.
To read the full article, please click here.